Delivering innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR® (ferric maltol), a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.